Ivan V Litvinov1, Michael T Tetzlaff2, Elham Rahme3, Youssef Habel3, David R Risser4, Pamela Gangar5, Michelle A Jennings2, Kevin Pehr1, Victor G Prieto2, Denis Sasseville1, Madeleine Duvic5. 1. Division of Dermatology, McGill University Health Centre, Montreal, Quebec, Canada. 2. Section of Dermatopathology, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 3. Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada. 4. Cancer Epidemiology and Surveillance Branch, Texas Cancer Registry, Department of State Health Services, Austin, Texas. 5. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: Cutaneous T-cell lymphomas (CTCLs) (mycosis fungoides and its leukemic variant, Sezary syndrome) are rare malignancies. Reports of the occurrence of mycosis fungoides in married couples and families raise the possibility of an environmental trigger for this cancer. Although it has been suggested that CTCL arises from inappropriate T-cell stimulation, to the authors' knowledge no preventable trigger has been identified to date. METHODS: Using region, zip code, age, sex, and ethnicity, the authors analyzed the demographic data of 1047 patients from Texas who were seen in a CTCL clinic at The University of Texas MD Anderson Cancer Center during 2000 through 2012 (the MDACC database) and 1990 patients who were recorded in the population-based Texas Cancer Registry between 1996 and 2010. Subsequently, data from both databases were cross-analyzed and compared. RESULTS: The current study findings, based on the MDACC database, documented geographic clustering of patients in 3 communities within the Houston metropolitan area, in which CTCL incidence rates were 5 to 20 times higher than the expected population rate. Analysis of the Texas Cancer Registry database defined the CTCL population rate for the state to be 5.8 cases per million individuals per year (95% confidence interval, 5.5-6.0 per million individuals per year), thus confirming the observations from the MDACC database and further highlighting additional areas of geographic clustering and regions spared from CTCL in Texas. CONCLUSIONS: The current study documented geographic clustering of CTCL cases in Texas and argued for the existence of yet unknown external causes/triggers for this rare malignancy.
BACKGROUND:Cutaneous T-cell lymphomas (CTCLs) (mycosis fungoides and its leukemic variant, Sezary syndrome) are rare malignancies. Reports of the occurrence of mycosis fungoides in married couples and families raise the possibility of an environmental trigger for this cancer. Although it has been suggested that CTCL arises from inappropriate T-cell stimulation, to the authors' knowledge no preventable trigger has been identified to date. METHODS: Using region, zip code, age, sex, and ethnicity, the authors analyzed the demographic data of 1047 patients from Texas who were seen in a CTCL clinic at The University of Texas MD Anderson Cancer Center during 2000 through 2012 (the MDACC database) and 1990 patients who were recorded in the population-based Texas Cancer Registry between 1996 and 2010. Subsequently, data from both databases were cross-analyzed and compared. RESULTS: The current study findings, based on the MDACC database, documented geographic clustering of patients in 3 communities within the Houston metropolitan area, in which CTCL incidence rates were 5 to 20 times higher than the expected population rate. Analysis of the Texas Cancer Registry database defined the CTCL population rate for the state to be 5.8 cases per million individuals per year (95% confidence interval, 5.5-6.0 per million individuals per year), thus confirming the observations from the MDACC database and further highlighting additional areas of geographic clustering and regions spared from CTCL in Texas. CONCLUSIONS: The current study documented geographic clustering of CTCL cases in Texas and argued for the existence of yet unknown external causes/triggers for this rare malignancy.
Authors: E Hodak; M Lapidoth; K Kohn; D David; B Brautbar; K Kfir; N Narinski; S Safirman; M Maron; K Klein Journal: Br J Dermatol Date: 2001-12 Impact factor: 9.302
Authors: Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer Journal: Blood Date: 2005-02-03 Impact factor: 22.113
Authors: Maria M Morales-Suárez-Varela; Jorn Olsen; Preben Johansen; Linda Kaerlev; Pascal Guénel; Patrick Arveux; Gun Wingren; Lennart Hardell; Wolfgang Ahrens; Andreas Stang; Agustin Llopis; Franco Merletti; Juan Jose Aurrekoetxea; Giovanna Masala Journal: J Occup Environ Med Date: 2004-03 Impact factor: 2.162
Authors: Jessica Shin; Stefano Monti; Daniel J Aires; Madeleine Duvic; Todd Golub; David A Jones; Thomas S Kupper Journal: Blood Date: 2007-07-16 Impact factor: 22.113
Authors: Gabriella Fabbrocini; Maria Triassi; Maria Chiara Mauriello; Guglielma Torre; Maria Carmela Annunziata; Valerio De Vita; Francesco Pastore; Vincenza D'Arco; Giuseppe Monfrecola Journal: Cancers (Basel) Date: 2010-11-24 Impact factor: 6.639
Authors: Ivan V Litvinov; Michael T Tetzlaff; Philippe Thibault; Pamela Gangar; Linda Moreau; Andrew K Watters; Elena Netchiporouk; Kevin Pehr; Victor G Prieto; Elham Rahme; Nathalie Provost; Martin Gilbert; Denis Sasseville; Madeleine Duvic Journal: Oncoimmunology Date: 2017-03-17 Impact factor: 8.110
Authors: Ivan V Litvinov; Elena Netchiporouk; Brendan Cordeiro; Marc-André Doré; Linda Moreau; Kevin Pehr; Martin Gilbert; Youwen Zhou; Denis Sasseville; Thomas S Kupper Journal: Clin Cancer Res Date: 2015-03-16 Impact factor: 12.531
Authors: L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov Journal: Curr Oncol Date: 2020-06-01 Impact factor: 3.677
Authors: Melania H Fanok; Amy Sun; Laura K Fogli; Vijay Narendran; Miriam Eckstein; Kasthuri Kannan; Igor Dolgalev; Charalampos Lazaris; Adriana Heguy; Mary E Laird; Mark S Sundrud; Cynthia Liu; Jeff Kutok; Rodrigo S Lacruz; Jo-Ann Latkowski; Iannis Aifantis; Niels Ødum; Kenneth B Hymes; Swati Goel; Sergei B Koralov Journal: J Invest Dermatol Date: 2017-11-08 Impact factor: 8.551
Authors: Ivan V Litvinov; Anna Shtreis; Kenneth Kobayashi; Steven Glassman; Matthew Tsang; Anders Woetmann; Denis Sasseville; Niels Ødum; Madeleine Duvic Journal: Oncoimmunology Date: 2016-06-06 Impact factor: 8.110
Authors: Kevin A Henry; Daniel Wiese; Aniruddha Maiti; Gerald Harris; Slobodan Vucetic; Antoinette M Stroup Journal: Cancer Causes Control Date: 2021-06-12 Impact factor: 2.506
Authors: Lindsay Clough; A Rana Bayakly; Kevin C Ward; Mohammad K Khan; Suephy C Chen; Mary Jo Lechowicz; Christopher R Flowers; Pamela B Allen; Jeffrey M Switchenko Journal: Cancer Date: 2020-01-14 Impact factor: 6.860
Authors: Philippe Lefrançois; Pingxing Xie; Linghua Wang; Michael T Tetzlaff; Linda Moreau; Andrew K Watters; Elena Netchiporouk; Nathalie Provost; Martin Gilbert; Xiao Ni; Denis Sasseville; David A Wheeler; Madeleine Duvic; Ivan V Litvinov Journal: Oncoimmunology Date: 2018-05-31 Impact factor: 8.110